Your browser doesn't support javascript.
loading
SELENBP1 overexpression in the prefrontal cortex underlies negative symptoms of schizophrenia.
Kim, Soojin; Kim, Seong-Wook; Bui, Mai Anh Thi; Kim, Yeji; Kim, Minsoo; Park, Jung-Cheol; Kim, Nam-Heon; Pyeon, Gyeong Hee; Jo, Yong Sang; Jang, Jaewon; Koh, Hae-Young; Jeong, Chae-Hong; Kang, Moonkyung; Kang, Hyo Jung; Lee, Yong-Woo; Stockmeier, Craig A; Seong, Je Kyung; Woo, Dong Ho; Han, Jung-Soo; Kim, Yeon-Soo.
Affiliation
  • Kim S; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Kim SW; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Bui MAT; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Kim Y; Research Center for Convergence Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.
  • Kim M; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Park JC; Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
  • Kim NH; Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
  • Pyeon GH; School of Psychology, Korea University, Seoul 02841, Republic of Korea.
  • Jo YS; School of Psychology, Korea University, Seoul 02841, Republic of Korea.
  • Jang J; Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Seoul 02455, Republic of Korea.
  • Koh HY; Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Seoul 02455, Republic of Korea.
  • Jeong CH; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Kang M; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Kang HJ; Department of Life Science, Chung-Ang University, Seoul 06911, Republic of Korea.
  • Lee YW; Department of Biomedical Laboratory Science, Inje University, Gimhae 50834, Republic of Korea.
  • Stockmeier CA; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216.
  • Seong JK; Korea Mouse Phenotyping Center, Seoul National University, Seoul 08826, Republic of Korea.
  • Woo DH; Research Center for Convergence Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.
  • Han JS; Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
  • Kim YS; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
Proc Natl Acad Sci U S A ; 119(51): e2203711119, 2022 12 20.
Article in En | MEDLINE | ID: mdl-36512497
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Type: Article